Institut Català D'oncologia

L'Hospitalet de Llobregat 08907

0 studies enrolling now · 2 studies all time

What they study most

Anaplastic Large-Cell Lymphoma, Lymphoma, B-cell, Lymphoma, Large B-cell, Diffuse, Non-Hodgkin Lymphoma, T-Cell Lymphoma

Studies at this site

• ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas — Completed
• Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) — Stopped early